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Background: Patients report varied barriers to HIV care across
multiple domains, but specific barrier patterns may be driven by
underlying, but unobserved, behavioral profiles.
Methods: We traced a probability sample of patients lost to follow-
up (.90 days late) as of July 31, 2015 from 64 clinics in Zambia.
Among those found alive, we ascertained patient-reported reasons
for care disruptions. We performed latent class analysis to identify
patient subgroups with similar patterns of reasons reported and
assessed the association between class membership and care status
(ie, disengaged versus silently transferred to a new site).
Results: Among 547 patients, we identified 5 profiles of care
disruptions: (1) “Livelihood and Mobility” (30.6% of the popula-
tion) reported work/school obligations and mobility/travel as reasons
for care disruptions; (2) “Clinic Accessibility” (28.9%) reported
challenges with attending clinic; (3) “Mobility and Family”
(21.9%) reported family obligations, mobility/travel, and transport-
related reasons; (4) “Doubting Need for HIV care” (10.2%)
reported uncertainty around HIV status or need for clinical care,
and (5) “Multidimensional Barriers to Care” (8.3%) reported
numerous (mean 5.6) reasons across multiple domains. Patient
profiles were significantly associated with care status. The “Doubt-
ing Need for HIV Care” class were mostly disengaged (97.9%),
followed by the “Multidimensional Barriers to Care” (62.8%),
“Clinic Accessibility” (62.4%), “Livelihood and Mobility”
(43.6%), and “Mobility and Family” (23.5%) classes.
Conclusion: There are distinct HIV care disruption profiles that are
strongly associated with patients’ current engagement status. Inter-
ventions targeting these unique profiles may enable more effective
and tailored strategies for improving HIV treatment outcomes.
Key Words: latent class analysis, phenotypes, barriers to care,
retention in care, loss to follow-up, transfer, disengagement
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INTRODUCTION
Despite tremendous scale-up of HIV treatment in sub-
Saharan Africa over the past decade, HIV treatment outcomes
remain suboptimal, in large part because of poor retention in
care.1 Effective strategies to improve engagement are
urgently needed as upward of 25% of patients will disengage
from care.2,3 There is also increasing recognition that these
strategies—as opposed to being uniform and directed toward
the entire patient population—will also need to be more
targeted to account for the significant diversity in the patient
population.4–6 It is thus imperative that we develop a more
comprehensive understanding of the heterogeneity in the HIV
patient population to develop such targeted strategies to
optimize the impact of the global HIV treatment response.
Although patients report a diversity of individual barriers,
individual patients may also experience specific patterns of
barriers—defined by individual-, social-, and systems-level
characteristics—that ultimately drive their behavior. Existing
approaches that use a priori (even if theory-based) categories to
describe barriers do not make use of the data itself to empirically
explore these groupings. Latent class analysis (LCA) is a data-
driven approach to identify latent (or unobserved) subgroups
hidden within the data, thereby revealing coherent groupings that
potentially point to mechanisms of behavior.7 In leveraging multi-
dimensional data to identify subgroups with unique data patterns,
LCA can capture potentially complex associations and interaction
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between different variables. Rather than targeting interventions
based on only a single sociodemographic characteristic (eg, age or
sex) or risk factors (eg, stigma or food insecurity), LCA can
identify patient profiles that may better capture the heterogeneity
in behavioral patterns and risk profiles. Ultimately, focusing on
more holistic profiles rather than single characteristics may be a
more effective strategy for developing and targeting interventions
for a diverse patient population.
We sought to identify unique patient profiles of HIV care
disruptions in Zambia using latent class methods. We used LCA
and data on patient-reported reasons for loss to follow-up among
a population-representative sample of patients in Zambia to
identify profiles of HIV care disruptions and examined their
associations with engagement in care status. This in-depth
characterization of patient profiles ultimately permits a better
understanding of the drivers of patient behaviors and clearly lays
forth actionable targets for improving retention in care.
METHODS
Patient Population and Setting
We analyzed a cohort of adults (18 years old or older)
living with HIV on antiretroviral therapy (ART) who were lost to
follow-up (LTFU, defined as being greater than 90 days late to a
scheduled appointment or 180 days from any recorded clinic
encounter if no scheduled appointment was found) from public
health clinics in Zambia and who were then found alive after
actively being traced in the field. Patients were identified as part
of the Better Information for Health in Zambia study, in which
we used previously validated methods to undertake multistage
random sampling and tracing patients in the community to obtain
population-representative estimates of retention and mortality.8–10
We first identified all patients who had made at least one clinic
visit after August 1, 2013 but who were LTFU as of July 31,
2015 from 64 health facilities in 4 of Zambia’s 10 provinces. In
the first sampling stage, we selected a stratified random sample of
32 of the 64 health facilities to conduct tracing activities. At these
32 selected facilities, we then identified a random sample of the
patients who were LTFU. These patients were then traced
between September 2015 and July 2016. Study clinics are
operated by the Zambian Ministry of Health and receive technical
support from the Centre for Infectious Disease Research in
Zambia, a Zambian non-governmental organization.
Measurements
We asked patients who were found alive during phone or
in-person tracing and self-reported an HIV care disruption (ie,
either currently out of care or transferred to another facility after
disengaging from their original facility) an open-ended question
about why their care was disrupted (“Why did you stop going to
any clinic for your HIV care?” or “Why are you going to your
new clinic instead of your previous one?” depending on current
care status). Patients responded to the open-ended prompt and the
reasons they reported were then recorded by trained interviewers
using prespecified categories [which were identified based on
literature review, input from key informants, and prior experience
using this method to ascertain patient-reported barriers to care
(see Table 1, Supplemental Digital Content, http://links.lww.
com/QAI/B555)].11 We obtained sociodemographic (eg, age,
sex, clinic site), clinical (date of ART initiation, CD4 counts), and
visit history (dates, scheduled appointment) measurements from
the national electronic medical record system used in routine HIV
care in Zambia. To populate the electronic medical record,
providers use standardized paper clinical forms during patient




We performed LCA to identify distinctive patient profiles
of care disruptions using data on patient-reported reasons for
LTFU. This method is based on the premise that the population
is made of unique, but unobserved, subpopulations that have
distinct patterns in their data, and it uses the observed data to
identify what these unique patterns are, which patients may
belong to a particular subgroup, and how these subgroups are
distributed in the population.7 We used LCA to identify
subgroups of LTFU patients that had similar patterns in both
the types of reasons patients reported for their care disruption
and the total number of reasons they reported. Because there
were initially 65 possible reasons for care disruptions, we
undertook an initial round of data reduction based on theory,
literature review, and contextual experience to combine similar
reasons into 15 categories that could then be analyzed using
LCA (see Tables 1 and 2, Supplemental Digital Content, http://
links.lww.com/QAI/B555). We then performed LCA to estimate
both the pattern of reasons for care disruptions for each class (ie,
the probability of reporting particular reasons and the mean
number of reasons reported) and the percent of patients expected
to belong to each class. Since the number of groups is not
known a priori, we systematically tested models with differing
number of groups and then selected a final model that was
optimized for fit and parsimony—using the Akaike Information
Criterion and Bayesian Information Criterion in text—and
interpretability—using contextual knowledge.7,12 Based on this
final model, we then estimated each individual’s probability of
belonging to a specific latent class given their reported reasons
(ie, estimated posterior probabilities based on Bayes Theorem)
and assigned them to the latent class to which they were most
likely to belong (ie, the maximal probability rule).12
We assessed adequacy and fit of the final model and
group assignment using several established metrics: (1)
comparing the proportion assigned to each latent class using
maximal probability rule versus the estimated distribution
from the initial model, (2) estimating the average posterior
probability for individuals assigned to each class using the
maximal probability rule, (3) calculating the odds ratio of
being assigned to the correct latent class based on posterior
probabilities, and (4) calculating the entropy statistic, an
indicator of separation between latent classes.7,12
Baseline Factors Associated with Latent Class
We described baseline patient sociodemographic, clin-
ical, and facility-level characteristics for members of each
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latent class (using latent class assignments based on maxi-
mum posterior probabilities). In addition, we used multino-
mial logistic regression to assess for patient characteristics
associated with class membership and then estimated the
predictive margins of the expected distribution of latent
classes stratified across each characteristic.
Association Between Latent Class and Care Status
Finally, we sought to assess the association between
latent class membership and whether patients remained out
of care or had silently transferred to a new facility. We
performed unadjusted and adjusted Poisson regression
with robust variances and estimated the marginal preva-
lence of being out of care. Adjusted models included latent
class membership and sociodemographic, clinical, and
facility-level characteristics based on directed acyclic
graphs. We also assessed for an interaction between latent
class and sex.
All analyses incorporated sampling weights based on
the inverse of the probability of being selected for tracing to
yield population-representative estimates.8–10 We used mul-
tiple imputation (n = 20) to address missingness in predictor
variables (ie, enrollment CD4 count, enrollment WHO
Stage, marital status, and education status).13 As an
individual’s class membership is not observed and only
predicted based on individuals’ own observed data, we also
conducted sensitivity analyses that account for potential
misclassification arising from the uncertainty in latent class
assignments (see Appendix 1, Supplemental Digital Con-
tent, http://links.lww.com/QAI/B555).12,14 All analyses
were conducted using Stata (Version 16.1, College Station,
TX). The study was approved by the University of Zambia
Biomedical Research Ethics Committee (UNZABREC) and
institutional review boards at the University of California,
San Francisco and the University of Alabama, Birmingham
School of Medicine. All participants provided informed
consent before being interviewed.
FIGURE 1. Patient flowchart. As of July 1, 2015, 28,117
patients who had ever initiated ART were considered LTFU
across 64 sites and 2898 were randomly selected for active
tracing from 32 sites. Among patients selected for tracing,
1007 (34.8%) were found alive without a care disruption,
412 (14.2%) had died, and we were unable to trace 932
(32.2%). We ascertained patient-reported reasons for care
disruptions among the 547 (18.9%) patients who we found
alive with a confirmed care disruption.
TABLE 1. Baseline Patient Characteristics
Baseline Patient Characteristics, n = 547
Female sex, n (%) 326 (59.6%)
Median age at LTFU, yrs (IQR) 35 (30–41)
Median enrollment CD4 count*, cells/mL (IQR) 239 (130–366)






Median time from enrollment to ART initiation, d (IQR) 27 (14–85)
Median time from ART initiation to LTFU, yrs (IQR) 1.3 (0.3–3.5)













Lower–Mid basic 199 (36.4%)
Upper basic/Secondary 243 (44.4%)
College/University 67 (12.2%)
Unknown 7 (1.3%)













Care status at time of interview, n (%)
Disengaged 255 (46.6%)
Silently transferred 292 (53.4%)
*Missing for 103 patients.
IQR, interquartile range; LTFU, loss to follow-up.
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RESULTS
Patient Characteristics
After multistage sampling and active tracing of selected
patients in the community, we interviewed 547 participants
who were found alive and in-person regarding reasons for
their care disruption (Fig. 1). 326 (59.6%) patients were
female the median age at the time of LTFU was 35 years
(IQR 30–41), and the median time from ART initiation to
LTFU was 1.3 years (IQR 0.3–3.5) (Table 1). The patient-
reported reasons for LTFU are presented in Table 2,
Supplemental Digital Content, http://links.lww.com/QAI/
B555. At the time of tracing, 255 (46.6%) reported being
out care, whereas 292 (54.4%) reported having transferred to
a new facility since their last visit at their original facility
(Table 1).
Description of Latent Classes
We selected the model with 5 latent classes (ie,
profiles of care disruptions) based on model fit and
interpretability (Fig. 2). In this model, the first class were
patients who reported predominately work/school obliga-
tions and mobility/travel challenges (mean 2.4 reasons) as
reasons for their care disruptions (“Livelihood and Mobil-
ity” group) and accounted for 30.6% [95% confidence
FIGURE 2. Profiles of care disruptions (n = 547). Patient profiles of care disruption are based on latent class models based on the
patient-reported reasons for care disruptions and the number of reasons a patient reported. The estimated proportion of patients
in each latent class are in parentheses at the top, and bars correspond to the probability of reporting a particular reason for care
disruption within each class. Models used population-representative sampling weights after tracing a random sample of patients
who were considered lost to follow-up as of July 31, 2015.
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interval (CI): 25.5% to –36.3%] of the population. The
second class primarily reported various issues (mean 2.1)
associated with attending clinic (eg, rude health care
workers, quality of care, time spent in clinic) [“Clinical
Accessibility” group, 28.9% (95% CI: 20.2% to 39.4%)].
The third class reported mobility/travel, family obligations,
and transport issues (mean 1.4) as reasons for care
disruptions [“Mobility and Family” group, 21.9% (95%
CI: 16.3% to 28.8%) of the population]. The fourth class
were patients who reported doubts regarding their HIV
status or need to routinely come to clinic (mean 2.1)
[“Doubting need for HIV Care” group, 10.2% (95% CI:
5.6% to –18.0%)]. Finally, the fifth class were patients who
reported numerous (mean 5.6) issues across multiple
domains (structural, clinic-level, and psychosocial) as
reasons for their care disruption (“Multidimensional Bar-
riers to Care” group, 8.3% [95% CI: 3.3%–19.4%] of the
population) (Fig. 2, and Table 3, Supplemental Digital
Content, http://links.lww.com/QAI/B555). Diagnostic met-
rics demonstrate that our final model had very good fit and
separation between classes (Table 2).
Baseline Factors Associated With Latent
Class Membership
There were several notable trends when examining
baseline characteristics associated with latent class member-
ship, although few were strongly predictive of class member-
ship (Tables 3 and 4). The “Livelihood and Mobility” class
trended toward being male, having more prior episodes of
LTFU, and being from Lusaka province (which includes the
capital city and surrounding areas). Patients with “Clinic
Accessibility” problems were more likely to be women, from
urban areas, and have more advanced disease at enrollment.
The “Mobility and Family” class trended toward having no
prior LTFU and were less likely to be from Lusaka. Those
“Doubting the Need for HIV Care” trended toward having
lower WHO stage, being either earlier in their care (ie, LTFU
occurred within 6 months of ART initiation) or with over 3
prior episodes of LTFU, being widowed, and having lower
education. Finally, patients with “Multidimensional Barriers
to Care” trended toward being male, single, more educated,
from rural areas, and having had longer periods in care with
multiple episodes of prior LTFU.
Association Between Latent Class and
Care Status
Latent class membership was strongly associated with
patients’ current care status (ie, whether they remained out of
care or had silently transferred to a new facility) in both
unadjusted and adjusted analyses. The “Doubting Need for
HIV Care” class had the highest prevalence of being out of
care [97.9% (95% CI: 84.2% to –100.0%)] followed by those
in the “Multidimensional Barriers to Care” class [62.8% out
of care (95% CI: 44.2% to –81.3%)] and the “Clinic
Accessibility” class [62.4% out of care (95% CI: 51.0% to
–73.8%)]. In contrast, patients in the “Livelihood and
Mobility” class [43.6% (95% CI: 34.5% to –52.7%) out of
care] and “Mobility and Family” class [23.5% (95% CI:
14.4% to –32.6%) out of care] were more likely to have
silently transferred a new facility (Table 5). Among the
“Livelihood and Mobility” and “Mobility and Family”
classes, the association with care status differed across sex,
with males having a trend towards an increased proportion
out of care, though this interaction was not statistically
significant overall (P = 0.246) (Fig. 3).
DISCUSSION
We used LCA methods to characterize 5 distinctive
profiles of care disruptions based on the types and number of
patient-reported reasons for LTFU in a population-
representative sample of patients LTFU from HIV care in
Zambia. In our model, 30.6% of patients reported predomi-
nately work/school obligations and mobility/travel (“Liveli-
hood and Mobility” group), 28.9% reported issues associated
with attending clinic (“Clinical Accessibility” group), 21.9%
reported mobility/travel, family obligations, and transport
issues (“Mobility and Family” group”), 10.2% reported
doubts regarding their HIV status or need to attend clinic
(“Doubting need for HIV Care” group), and 8.3% reported
numerous (mean 5.6) barriers across multiple domains
(“Multidimensional Barriers to Care” group) as the reasons
for their care disruption. Although there were some notable
TABLE 2. Metrics of Adequacy and Fit of Latent Class Model











Livelihood and mobility 0.983 128 0.311 0.306 0.858
Clinic accessibility 0.940 48 0.247 0.289
Mobility and family 0.811 12 0.270 0.219
Doubting need for HIV care 0.899 80 0.100 0.102
Multidimensional barriers to care 0.951 252 0.072 0.083
Good model fit indicated by 1) average posterior probability greater than 0.7 for each group, 2) odds ratio of correct classification greater than 5 for each group; 3) close
correspondence between the estimated group distribution based on using posterior probabilities and the maximal probability rule compared with the estimated group distribution from
the initial model; and 4) an entropy greater than 0.8.
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trends, baseline characteristics were not strongly associated
with belonging to a particular class. However, patients’ care
disruption profiles were the factor most strongly associated
with whether they remained out of care or had silently
transferred to a new facility after LTFU. These findings
highlight how identifying unique patient profiles can deepen
our understanding of heterogeneity in patients’ behaviors and
care outcomes and inform more targeted strategies for
improving retention in care.
The profiles of care disruptions that we identified
among patients LTFU from HIV care have important and
durable implications for optimizing the public health response
to HIV. To date, many interventions strategies have only
focused on addressing a single type of barrier at a time (eg,
travel vouchers for transport-related barriers, decreasing visit
frequency to reduce burden of accessing care, peer-navigators
for psychosocial support).4 These strategies are likely to be
effective in only a subset of the patient population, and there
is thus increasing recognition that the next phase of the global
response to the HIV epidemic will require more targeted
approaches.4,6,15 Focusing on patient profiles that speak more
to the underlying drivers of patient behaviors will be crucial
when developing and implementing the next-generation of
intervention strategies. First, these profiles highlight that more
holistic strategies that seek to target the multiple barriers an
individual may face, rather than individual ones, may be more
effective at improving retention.16 Second, they establish that
several distinct intervention strategies will need to be
implemented in order to address the care needs of the entire
population.6 For example, patients with competing work
obligations may require increased flexibility and decreased
burden for receiving care (ie, extending visit intervals). For
TABLE 3. Baseline Patient Characteristics by Latent Class









Female sex, percent 47.4% 65.6% 64.4% 58.2% 52.0%
Median age at LTFU, yrs (IQR) 37 (31–41) 36 (30–42) 35 (28–40) 36 n(31–42) 36 (32–39)
Median enrollment CD4 count, cells/mL (IQR) 213 (125–340) 214 (130–317) 236 (106–397) 217 (118–407) 167 (113–328)
Enrollment WHO stage, percent
I 43.0% 46.7% 55.7% 63.7% 43.1%
II 17.9% 17.5% 12.3% 19.3% 18.8%
III 30.8% 32.1% 27.3% 15.6% 34.4%
IV 8.3% 3.7% 4.7% 1.4% 3.7%
Median time from ART initiation to LTFU, yrs (IQR) 2.0 (0.6–4.2) 1.4 (0.5–2.9) 0.9 (0.1–2.7) 0.2 (0.0–1.6) 2.7 (0.3–4.0)
Prior episodes of LTFU, percent
0 34.8% 52.7% 58.2% 68.8% 51.5%
1 37.3% 38.6% 28.4% 19.5% 27.7%
2 21.9% 5.4% 9.2% 3.5% 9.5%
.3 6.0% 3.4% 4.2% 8.1% 11.3%
Marital status, percent
Single 19.4% 13.8% 21.0% 19.8% 29.3%
Married 63.5% 55.3% 58.2% 53.1% 45.6%
Divorced 11.5% 17.2% 15.0% 9.7% 19.6%
Widowed 5.6% 13.8% 5.8% 17.3% 5.5%
Education, percent
None 2.2% 3.4% 5.2% 8.5% 0.5%
Lower–Mid basic 31.6% 42.7% 27.8% 38.5% 31.0%
Upper basic/Secondary 41.2% 43.0% 53.3% 33.0% 44.8%
College/University 25.0% 10.8% 13.6% 20.0% 23.6%
Facility type, percent
Urban 75.1% 75.2% 67.1% 79.6% 67.5%
Rural 3.9% 4.5% 6.2% 6.6% 13.8%
Hospital 21.1% 20.3% 26.7% 13.8% 18.7%
Province, percent
Lusaka 74.6% 68.5% 56.6% 72.0% 71.4%
Eastern 5.4% 9.1% 14.5% 9.7% 4.5%
Southern 6.3% 12.2% 15.8% 14.2% 15.8%
Western 13.8% 10.2% 13.1% 4.2% 8.4%
All values calculated accounting for sampling weights included in the initial latent class model.
IQR, interquartile range; LTFU, loss to follow-up.
LCA of Reasons of HIV Care DisruptionsJ Acquir Immune Defic Syndr  Volume 86, Number 1, January 1, 2021
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. www.jaids.com | 67
others, travel and mobility are unavoidable and facilitating
transfers (which are often associated with prolonged gaps in
care17) so they are seamless is needed. Another large group
will likely benefit from improving the patient-centeredness
and overall experience of attending HIV clinics,18 while only
a smaller group might may require more intensive
TABLE 4. Predictive Margins of Latent Class Distribution Across Baseline Patient Characteristics From Multinomial Logistic
Regression
Predictive Margins of Latent Class Distribution Across Baseline Patient Characteristics from Multinomial Logistic Regression, n = 547





Overall 30.6% (25.5% to –36.3%) 28.9% (20.2% to –39.4%) 21.9% (16.3% to –28.8%) 10.2% (5.6% to –18.0%) 8.3% (3.3% to –19.4%)
Sex
Female 27.1% (20.9% to –33.4%) 29.2% (22.8% to –35.5%) 28.3% (22.0% to –34.7%) 8.9% (5.4% to –12.4%) 6.5% (2.9% to –10.1%)
Male 36.2% (28.1% to –44.3%) 18.8% (12.5% to –25.2%) 24.7% (17.0% to –32.4%) 12.1% (6.5% to –17.8%) 8.1% (3.4% to –12.9%)
Age at LTFU
,25 yrs old 23.3% (9.3% to –37.4%) 25.8% (11.6% to –40.0%) 35.5% (18.9% to –52.2%) 10.7% (0.7% to –20.7%) 4.7% (0.0% to –10.6%)
25–35 yrs old 34.2% (26.1% to –42.4%) 23.6% (16.9% to –30.3%) 24.7% (17.4% to –32.0%) 9.8% (4.8% to –14.7%) 7.7% (3.1% to –12.4%)
35–50 yrs old 30.3% (23.1% to –37.6%) 24.3% (17.5% to –31.0%) 25.4% (18.5% to –32.4%) 11.2% (6.2% to –16.2%) 8.8% (4.0% to –13.5%)
.50 yrs old 29.2% (9.1% to –49.3%) 29.9% (13.3% to –46.5%) 36.3% (16.6% to –55.9%) 4.7% (0.0% to –10.2%) 0.0% (0.0% to –0.0%)
Enrollment CD4 count
,200 cells/mL 28.0% (21.3% to –34.6%) 27.0% (19.7% to –34.2%) 26.8% (19.8% to –33.9%) 10.6% (5.1% to –16.0%) 7.7% (3.3% to –12.0%)
200–350 cells/mL 33.5% (23.9% to –43.0%) 29.6% (20.7% to –38.5%) 23.0% (14.7% to –31.2%) 7.8% (3.2% to –12.4%) 6.2% (1.4% to –11.1%)
350–500 cells/mL 37.5% (24.0% to –51.0%) 13.3% (5.0% to –21.5%) 30.9% (17.4% to –44.4%) 11.0% (2.6% to –19.4%) 7.3% (0.7% to –14.0%)
.500 cells/mL 31.2% (16.1% to –46.4%) 16.8% (5.9% to –27.7%) 32.5% (17.5% to –47.6%) 12.1% (1.7% to –22.6%) 7.4% (0.0% to –15.2%)
WHO stage
I 29.5% (22.5% to –36.6%) 21.3% (14.9% to –27.8%) 29.7% (22.2% to –37.2%) 12.1% (7.1% to –17.1%) 7.3% (2.7% to –11.9%)
II 37.5% (23.8% to –51.2%) 25.3% (14.3% to –36.3%) 18.2% (9.2% to –27.3%) 11.9% (3.3% to –20.6%) 7.1% (1.0% to –13.1%)
III 28.4% (19.5% to –37.3%) 30.8% (20.5% to –41.0%) 26.9% (17.0% to –36.9%) 5.9% (1.8% to –9.9%) 8.0% (2.9% to –13.2%)
IV 41.7% (17.9% to –65.4%) 23.4% (1.8% to –45.0%) 28.9% (7.6% to –50.2%) 2.8% (0.0% to –8.1%) 3.3% (0.0% to –7.5%)
Time to LTFU
,6 mo 31.3% (19.7% to –42.9%) 17.7% (9.8% to –25.6%) 28.3% (19.1% to –37.6%) 16.9% (7.8% to –26.0%) 5.7% (1.3% to –10.2%)
6 months-2 yrs 30.1% (20.6% to –39.7%) 33.6% (23.9% to –43.3%) 22.4% (14.7% to –30.1%) 10.1% (4.5% to –15.8%) 3.7% (0.0% to –8.5%)
2–5 yrs 29.5% (19.4% to –39.6%) 26.6% (17.0% to –36.3%) 27.6% (17.1% to –38.1%) 1.9% (0.2% to –3.6%) 14.4% (4.5% to –24.2%)
.5 yrs 35.4% (21.6% to –49.2%) 17.6% (7.4% to –27.7%) 32.8% (17.2% to –48.5%) 7.6% (0.8% to –14.4%) 6.7% (0.0% to –14.3%)
Prior episodes of LTFU
0 22.1% (14.8% to –29.5%) 29.2% (21.1% to –37.3%) 30.7% (22.6% to –38.8%) 9.3% (5.7% to –12.9%) 8.7% (3.0% to –14.4%)
1 35.9% (25.1% to –46.7%) 24.3% (16.8% to –31.8%) 24.1% (15.7% to –32.6%) 10.0% (2.9% to –17.1%) 5.7% (1.6% to –9.8%)
2 54.2% (37.5% to –70.9%) 12.2% (2.3% to –22.1%) 21.5% (9.0% to –34.0%) 8.3% (0.0% to –18.3%) 3.8% (0.1% to –7.6%)
.3 25.9% (7.1% to –44.8%) 12.3% (0.0% to –24.8%) 15.5% (0.0% to –32.0%) 33.2% (6.9% to –59.5%) 13.1% (0.0% to –28.0%)
Marital status
Single 35.1% (23.9% to –46.3%) 17.5% (8.6% to –26.4%) 25.7% (15.5% to –35.9%) 10.8% (2.4% to –19.1%) 10.9% (1.3% to –20.5%)
Married 32.8% (26.2% to –39.5%) 24.9% (18.7% to –31.1%) 27.9% (21.9% to –33.9%) 9.0% (5.2% to –12.8%) 5.4% (2.6% to –8.1%)
Divorced 23.9% (12.3% to –35.5%) 25.5% (14.6% to –36.4%) 32.4% (18.9% to –45.9%) 7.8% (0.0% to –15.9%) 10.3% (2.0% to –18.6%)
Widowed 22.6% (7.8% to –37.5%) 35.7% (18.9% to –52.5%) 16.9% (5.1% to –28.7%) 17.8% (5.3% to –30.2%) 7.0% (0.0% to –17.3%)
Education
None 21.2% (25.0% to 47.3%) 21.9% (3.3% to –40.4%) 31.9% (9.6% to –54.3%) 23.9% (0.0% to –47.9%) 1.1% (0.0% to –6.7%)
Lower–Mid basic 29.2% (20.6% to –37.8%) 31.0% (22.3% to –39.7%) 21.6% (14.6% to –28.5%) 11.7% (5.5% to –17.9%) 6.5% (2.7% to –10.4%)
Upper basic/Secondary 30.5% (23.5% to –37.5%) 23.5% (16.9% to –30.1%) 31.8% (24.5% to –39.1%) 7.3% (3.6% to –11.0%) 6.9% (3.3% to –10.4%)
College/University 37.6% (25.3% to –49.9%) 16.1% (6.1% to –26.1%) 24.0% (12.6% to –35.4%) 11.3% (3.0% to –19.6%) 11.0% (2.1% to –19.9%)
Facility type
Rural 25.7% (11.1% to –40.2%) 15.7% (7.1% to –24.3%) 23.4% (14.5% to –32.3%) 9.6% (2.4% to –16.8%) 25.7% (10.5% to –40.9%)
Urban 29.0% (23.7% to –34.2%) 26.7% (21.4% to –32.0%) 27.8% (22.4% to –33.2%) 10.7% (7.2% to –14.2%) 5.9% (2.8% to –8.9%)
Hospital 41.0% (28.4% to –53.5%) 8.8% (0.2% to –17.5%) 9.6% (2.4% to –16.8%) 26.7% (21.4% to –32.0%) 8.8% (0.2% to –17.5%)
Province
Eastern 16.3% (6.9% to –25.7%) 26.2% (15.9% to –36.4%) 42.5% (30.4% to –54.7%) 11.9% (4.0% to –19.9%) 3.1% (0.0% to –7.8%)
Lusaka 36.1% (29.4% to –42.8%) 23.4% (17.7% to –29.0%) 22.3% (16.4% to –28.1%) 9.6% (5.8% to –13.4%) 8.6% (4.3% to –13.0%)
Southern 16.2% (7.4% to –25.0%) 27.5% (16.9% to –38.1%) 33.9% (23.1% to –44.7%) 14.7% (7.2% to –22.2%) 7.7% (1.8% to –13.6%)
Western 29.7% (17.7% to –41.8%) 27.4% (13.8% to –41.0%) 33.9% (20.1% to –47.8%) 5.4% (0.0% to –11.7%) 3.5% (0.0% to –8.6%)
LTFU, loss to follow-up.
Mody et al J Acquir Immune Defic Syndr  Volume 86, Number 1, January 1, 2021
68 | www.jaids.com Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.
TABLE 5. Association Between Latent Class Membership and Being Out of Care








45.6% (35.3% to –55.8%) REF ,0.001 43.6% (34.5% to –52.7%) REF ,0.001
Clinic accessibility 62.0% (51.2% to –72.7%) 16.4% (1.5% to –31.2%) 62.4% (51.0% to –73.8%) 18.7% (3.8% to –33.7%)
Mobility and family 22.6% (13.6% to –31.6%) 223.0% (236.6% to 29.4%) 23.5% (14.4% to –32.6%) 220.1% (233.0% to 27.2%)
Doubting need for
HIV care
94.0% (85.4% to –100%) 48.4% (35.0% to –61.7%) 97.9% (84.2% to –111.6%) 54.3% (37.0% to –71.6%)
Multidimensional
barriers to care
64.6% (45.1% to –84.1%) 19.0% (23.0% to 41.0%) 62.8% (44.2% to –81.3%) 19.2% (21.9% to 40.2%)
Sex
Female 44.5% (37.3% to –51.6%) REF 0.030 43.0% (36.8% to –49.2%) REF 0.005
Male 56.7% (48.2% to –65.3%) 12.3% (1.1% to –23.4%) 59.7% (50.3% to –69.0%) 16.7% (4.6% to –28.8%)
Age at LTFU
,25 yrs old 34.6% (20.1% to –49.1%) REF 0.14 39.0% (24.0% to –54.0%) REF 0.15
25–35 yrs old 55.2% (46.5% to –63.9%) 20.6% (3.7% to –37.5%) 56.8% (47.9% to –65.7%) 17.8% (1.1% to –34.5%)
35–50 yrs old 49.9% (41.5% to –58.3%) 15.3% (21.5% to 32.1%) 46.6% (38.9% to –54.2%) 7.5% (29.8% to 24.9%)
.50 yrs 38.0% (18.1% to –57.9%) 3.4% (221.2% to 28.0%) 44.6% (26.0% to –63.1%) 5.5% (218.6% to 29.7%)
Enrollment CD4 count
,200 cells/mL 49.9% (41.0% to –58.8%) REF 0.90 44.8% (37.4% to –52.2%) REF 0.24
200–350 cells/mL 54.5% (43.7% to –65.3%) 4.6% (29.4% to 18.6%) 51.2% (41.3% to –61.1%) 6.4% (26.2% to 19.0%)
350–500 cells/mL 55.0% (39.7% to –70.3%) 5.1% (212.6% to 22.9%) 59.5% (44.4% to –74.7%) 14.7% (22.6% to 32.1%)
.500 cells/mL 53.4% (36.1% to –70.6%) 3.5% (216.0% to 22.9%) 57.2% (42.5% to –71.9%) 12.4% (24.5% to 29.2%)
WHO stage
I 49.1% (40.8% to –57.4%) REF 0.96 48.3% (40.6% to –55.9%) REF 0.94
II 52.1% (38.4% to –65.7%) 3.0% (213.0% to 18.9%) 48.4% (36.8% to –60.0%) 0.1% (213.6% to 13.8%)
III 52.3% (41.4% to –63.3%) 3.2% (210.5% to 17.0%) 52.2% (41.7% to –62.8%) 3.9% (210.3% to 18.2%)
IV 52.3% (28.7% to –75.9%) 3.2% (221.8% to 28.2%) 52.9% (29.6% to –76.2%) 4.6% (220.9% to 30.1%)
Time to LTFU
,6 mo 48.2% (38.5% to –57.9%) REF 0.55 44.2% (34.2% to –54.2%) REF 0.48
6 months-2 yrs 53.5% (43.3% to –63.6%) 5.3% (28.8% to 19.3%) 50.7% (41.6% to –59.8%) 6.5% (26.8% to 19.8%)
2–5 yrs 52.0% (40.7% to –63.3%) 3.8% (211.1% to 18.7%) 57.3% (44.9% to –69.8%) 13.1% (24.8% to 31.0%)
.5 yrs 40.8% (26.9% to –54.6%) 27.4% (224.3% to 9.4%) 47.6% (32.0% to –63.2%) 3.3% (216.5% to 23.2%)
Prior episodes of LTFU
0 49.9% (42.3% to –57.4%) REF 0.99 52.1% (44.4% to –59.8%) REF 0.89
1 49.8% (39.8% to –59.7%) 20.1% (212.6% to 12.4%) 47.4% (38.4% to –56.4%) 24.7% (217.4% to 7.9%)
2 48.2% (31.7% to –64.6%) 21.7% (219.8% to 16.4%) 47.7% (31.3% to –64.0%) 24.5% (223.6% to 14.7%)
.3 49.9% (25.9% to –73.9%) 0.0% (225.1% to 25.1%) 46.7% (22.3% to –71.0%) 25.5% (231.5% to 20.5%)
Marital status
Single 51.6% (39.0% to –64.1%) 2.7% (211.8% to 17.3%) 0.53 54.8% (43.7% to –65.9%) 5.6% (27.8% to 19.0%) 0.29
Married 48.8% (41.5% to –56.2%) REF 49.2% (42.3% to –56.0%) REF
Divorced 57.1% (43.0% to –71.1%) 8.2% (27.6% to 24.1%) 54.7% (41.7% to –67.6%) 5.5% (29.6% to 20.5%)
Widowed 40.0% (22.4% to –57.6%) 28.8% (227.9% to 10.3%) 35.6% (20.7% to –50.5%) 213.6% (229.9% to 2.7%)
Education
None 62.1% (35.7% to –88.4%) REF 0.063 74.0% (52.9% to –95.1%) REF 0.007
Lower–Mid basic 59.1% (50.0% to –68.2%) 23.0% (230.9% to 24.9%) 56.5% (48.0% to –65.1%) 217.5% (240.0% to 5.1%)
Upper
basic/Secondary
45.2% (37.0% to –53.4%) 216.9% (244.5% to 10.7%) 47.9% (40.1% to –55.6%) 226.1% (249.2% to 23.1%)
College/University 41.5% (27.4% to –55.6%) 220.6% (250.4% to 9.3%) 37.2% (25.1% to –49.3%) 236.8% (260.3% to 213.3%)
Facility type
Rural 44.2% (32.5% to –56.0%) 29.8% (223.4% to 3.8%) 0.021 43.4% (32.5% to –54.2%) 27.8% (220.0% to 4.3%) 0.41
Urban 54.1% (47.3% to –60.8%) REF 51.2% (45.6% to –56.8%) REF
Hospital 36.1% (26.3% to –45.9%) 218.0% (229.9% to 26.0%) 44.8% (33.6% to –55.9%) 26.5% (219.1% to 6.1%)
(continued on next page)
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interventions that focus on providing psychosocial support
and counseling.4 Lastly, they suggest the need for different
interventions may vary across patient characteristics or the
stage at which a patient is in their care (eg, newer versus more
established patients).6 These are actionable insights that
remain durable for public health planning and should be
integrated with data on patient preferences19,20. Additional
research should now seek to elucidate what the most effective
intervention strategies will be for different patient profiles—
either through standard or more adaptive methods—as well as
how to effectively target these different strategies.
Our analysis also highlights how LCA represents an
innovative data-driven and patient-centric method for synthe-
sizing high-dimensional data on behavioral determinants.
Patients often experience multiple barriers concurrently and
it is often the interplay between them—not just one barrier—
that lead to disengagement.11,21–23 In our analysis, for
example, although 34.2% of patients reported mobility/
travel-related barriers to care, their patient characteristics
and outcomes varied depending on what other barriers were
also present (and thus to which latent class they belonged).
Those who also reported work/school obligations (ie, “Liveli-
hood and Mobility”) were more likely to be male, on ART for
longer, but also with more prior episodes of LTFU, and from
urban areas; those who also reported transportation and
family obligations (ie, “Mobility and Family”) were more
likely to be female with no prior LTFU; whereas those who
reported multiple additional barriers (ie, “Multidimensional
Barriers to Care”) also trended toward being male with
multiple episodes of prior LTFU, but from rural areas.
Depending on the overall barrier profile, outcomes varied
significantly across these groups (43.6%, 23.5%, and 62.4%
being out of care, respectively), but this association also
potentially differed across sex for the “Livelihood and
Mobility” and “Mobility and Family” class but not the
“Multidimensional barriers to care.” LCA synthesizes data
at the person-level (ie, identifying patient–level profiles or
phenotypes), which enables results to capture potentially
complex interactions with other determinants of patient
behavior (as opposed to methods that focus only on indi-
vidual barriers). This allows it to extend prior studies that
identified associations only with individual barriers to care (or
TABLE 5. (Continued ) Association Between Latent Class Membership and Being Out of Care




PPrevalence Risk Difference Prevalence Risk Difference
Province
Eastern 43.0% (32.3% to –53.8%) 212.6% (225.6% to 0.3%) 0.007 46.0% (35.4% to –56.7%) 27.5% (220.6% to 5.6%) 0.039
Lusaka 55.7% (48.5% to –62.9%) REF 53.5% (47.0% to –60.1%) REF
Southern 35.9% (25.5% to –46.3%) 219.8% (232.4% to 27.1%) 36.2% (27.3% to –45.0%) 217.4% (228.6% to 26.2%)
Western 33.2% (18.4% to –48.0%) 222.5% (239.0% to 26.0%) 40.4% (24.4% to –56.3%) 213.2% (230.7% to 4.3%)
LTFU, loss to follow-up.
FIGURE 3. Estimated prevalence of
disengagement by latent class and sex
(n = 547). Estimated prevalence of dis-
engagement based on marginal esti-
mates from an adjusted Poisson
regression that included an interaction
term latent class and sex. Regression
model incorporated population-repre-
sentative sampling weights after tracing
a random sample of patients who were
considered lost to follow-up as of July
31, 2015. The P-value for the interac-
tion term was 0.246.
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categories of barriers) and outcomes such as retention and
mortality.11,24,25 For this reason, LCA is also often considered
a patient-centered26—as opposed to variable-centered—ana-
lytic method, and has been used in several other studies to
assess the interplay between multidimensional constructs
such as HIV acquisition risk,27–31 health care seeking
behaviors,32,33 and engagement patterns34,35 at the person-
level. Ultimately, the use of LCA should be extended as it can
synthesize highly dimensional data to provide a more
comprehensive and patient-centered understanding of the
drivers of patient behaviors.
Leveraging patient profiles is also a promising strategy
for differentiating between higher- and lower-risk patients.
Traditional approaches to risk stratification have largely
focused on an individual sociodemographic (eg, age or sex),
socioeconomic (eg, food insecurity), or behavioral (eg,
stigma) risk factor, but these frequently only differentiate
between groups with relatively small absolute differences in
risk.23 For example, in our study, there was a 16.7%
difference in prevalence of being out of care between sexes
and a 17.8% difference across age groups. There was,
however, up to a 70% difference in prevalence of being out
of care across different profiles of care disruptions. Because
these profiles synthesize multidimensional behavioral char-
acteristics, they also can likely explain a substantially higher
proportion of the heterogeneity in risk across patients. This
also makes them vital components to risk stratification and
clinical prediction models.23 Future studies, however, still
need to longitudinally assess the association between these
profiles and patient outcomes, particularly considering that
patient profiles may change over time (eg, in response to life
disruptions that may also introduce new barriers to accessing
HIV care21,36–39). Nevertheless, emphasizing more holistic
patient profiles is an important advance to how we think about
patient risk factors.
There are several limitations of our study. First, our data
were collected cross sectionally and data were only based on
self-report. Thus, a patient’s care status at that time (ie, out of
care or silently transferred to a new facility) could have
influenced the reasons they reported for their initial care
disruption, and, because of logistical reasons, we did not
independently verify that patients who reported transferring to
a new facility had in fact done so. Second, our data were only
among patients who were considered LTFU from their
original clinic and did not include any patients who remained
in care. Prospective studies in a more generalized population
are needed to confirm the association between patient profiles
and outcomes. Third, our patient population also only
included adults from the general HIV clinic population. Thus,
our findings do not necessarily extend to other key popula-
tions of interest, such as adolescents and children, sex
workers, intravenous drug users, or men who have sex with
men. Additional studies, however, should leverage this
approach for identifying profiles more relevant to these
populations. Fourth, because of the large number of unique
reasons patients reported, we conducted an initial round of
data reduction based to combine similar reasons into a limited
number of categories that could then be analyzed with LCA.
This was done systematically based on theory, literature
review, and contextual experience. Finally, it is important to
note that the patient profiles that were identified are not
necessarily immutable properties and only represent data-
driven attempts to characterize patients’ subgroups based on
the available data. However, model diagnostics indicated a
very good fit for the data with clear differentiation between
latent classes, results were consistent in sensitivity analy-
ses12,14 (Tables 4 and 5, Supplemental Digital Content, http://
links.lww.com/QAI/B555), and our results do comport with
the existing literature on barriers to engagement in HIV
care.11,25
We used LCA and patient-reported reasons for care
disruptions to identify and characterize 5 distinctive profiles
of care disruptions that were strongly associated with
patients’ current care status in a population-representative
sample of patients LTFU from HIV care in Zambia. These
results underscore the importance of characterizing heteroge-
neity between patients in a holistic manner using data-driven
methods such as LCA. Ultimately, these findings can be used
to develop and implement more deliberate and targeted
interventions strategies to improve retention in care for the
diverse patient populations in public health HIV programs.
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